Ovarian cancer in elderly women

P. F. Conte, A. Romanini, I. Brunetti, P. Giannessi, A. Fanucchi, A. Gadducci

Research output: Contribution to journalArticlepeer-review


The incidence of ovarian cancer is > 50% in women aged ≤ 65 years. Histology and stage at diagnosis are both related to age, which appears to be an independent prognostic factor for survival in univariate analysis. Special conditions relating to the treatment of elderly women with ovarian cancer and the drugs active in this disease are discussed. New, less toxic combinations of paclitaxel (Taxol®, Bristol-Myers Squibb Company) and platinum-derived compounds appear to be promising.

Original languageEnglish
Pages (from-to)23-26
Number of pages4
JournalInternational Journal of Gynecological Cancer
Issue numberSUPPL. 1
Publication statusPublished - 1997


  • Carboplatin
  • Elderly patients
  • Ovarian cancer
  • Paclitaxel

ASJC Scopus subject areas

  • Cancer Research
  • Obstetrics and Gynaecology
  • Oncology

Fingerprint Dive into the research topics of 'Ovarian cancer in elderly women'. Together they form a unique fingerprint.

Cite this